|
|
||||||||
Letters to the Editor |
1
Lab. de Biochim. A, Hôpital Necker, 149 rue de Sèvres, 75015 Paris, France ,
2
Service d'Urol., Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
a Author for correspondence.
To the editor:
Although not yet a part of clinical chemical practice, molecular
techniques are sensitive tools to detect hematogenous spread of solid
tumor cells in cancer and may become routine methods in the coming
years (for review, see (1)). Provided
that mRNA is expressed exclusively in tumor tissue and not by normal
nucleated blood cells, its presence outside the organ identifies
already disseminated cells. We have recently found hematogenous spread
of prostate epithelial cells during radical prostatectomy
(2) as well as during the course of transurethral
resection of the prostate (unpublished data). The different mechanisms
underlying hematogenous dissemination of cells from prostate gland
remain largely unknown. Among the postulated factors
Acknowledgments
References
The following articles in journals at HighWire Press have cited this article:
![]() |
N. Hara, T. Kasahara, T. Kawasaki, V. Bilim, K. Obara, K. Takahashi, and Y. Tomita Reverse Transcription-Polymerase Chain Reaction Detection of Prostate-specific Antigen, Prostate-specific Membrane Antigen, and Prostate Stem Cell Antigen in One Milliliter of Peripheral Blood: Value for the Staging of Prostate Cancer Clin. Cancer Res., June 1, 2002; 8(6): 1794 - 1799. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |